Latest Options News

Locate Technologies moves closer to shifting its listing from the ASX to the New Zealand Exchange, completing a NZ$1 million share offer as part of its capital restructure.

MPR Australia Limited has completed the sale of its core renewable energy business for $19 million and is now exploring options including returning capital to shareholders or acquiring a new business via backdoor listing.

Jameson Resources Limited has updated its Employee Share Option Plan, approved at the 2025 AGM, aiming to better incentivize and retain key personnel while aligning employee interests with shareholders.

Omega Oil and Gas has secured a significant 19.43% equity interest in Elixir Energy, broadening its footprint in Queensland’s Taroom Trough and positioning itself for near-term exploration catalysts.

Warriedar Resources has officially been acquired by Capricorn Metals through a court-approved scheme, with shareholders exchanging their holdings for Capricorn shares and options. The takeover culminates in Warriedar’s imminent delisting from the ASX.

Warriedar Resources has completed its acquisition by Capricorn Metals through a court-approved scheme, with shareholders exchanging their shares for Capricorn stock. The takeover triggers Warriedar’s removal from the ASX next week.

ABx Group has successfully raised over $6 million through a share placement to fund rapid development of its Deep Leads rare earth project and ALCORE pilot plant in Tasmania.

Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.

New Frontier Minerals has raised $2.25 million to fast-track development of its Harts Range rare earths project, leveraging a promising new processing technology from Metallium Ltd. The capital injection supports an imminent drilling campaign and advances a mining lease application in Queensland.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Narryer Metals has outlined a substantial Exploration Target for its Rocky Gully Project in Western Australia, highlighting promising grades of scandium, rare earth elements, gallium, and potential titanium co-products. The company is gearing up for a new drilling campaign aimed at defining a maiden resource.